Incorporated in 2008, Mumbai based Sudarshan Pharma Industries Limited (SPIL) has a contract manufacturing facility to source and supply generic formulations. It is also engaged in import & export activities, and supply of specialty chemicals, API (Active Pharmaceutical Ingredients), and Intermediates. Based on clients’ specifications and requirements, they outsource the manufacturing facility from the suppliers in India and abroad.
The generic products supplied by the company have a wide application in paint, food, pharma, and adhesive industry. The company is involved in a contract manufacturing facility, supply and outsource of medicines and pharma formulation to hospitals, NGO, government and healthcare institutes. SPIL has 50 pharma formulations which are supplied under the brand name in the form of tablets, ointment, capsules, and injectable.
The company has its own sales force and distribution network in 5 states for ethical marketing of pharmaceutical formulation & products under the brand name in Indian and international markets. It also offers formulation development and QC services and provides customised solutions.
The competitive strengths of the company are:
1. Customer-centric and order-driven business model
2. Wide range of product offerings
3. Contract manufacturing facility arrangements
4. Strong distribution, marketing, and sales network
5. Diversified business operations
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31-Mar-21 | 9,926.02 | 19,372.82 | 267.12 | 2,250.74 | 1,296.05 | 2,977.09 |
| 31-Mar-22 | 13,752.18 | 35,755.89 | 530.37 | 2,977.53 | 2,002.63 | 3,059.24 |
| 30-Jun-22 | 14,703.74 | 10,587.79 | 225.37 | 3,192.45 | 2,217.55 | 4,737.02 |
| Amount in ₹ Lakhs |
Objects of the Issue
The Company intends to utilize the Net Fresh Issue Proceeds for the following Objects:
- Working Capital Requirements
- General Corporate Purposes.
Sudarshan Pharma Industries IPO Details
| IPO Date | Mar 9, 2023 to Mar 14, 2023 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price | ₹71 to ₹73 per share |
| Lot Size | 1600 Shares |
| Issue Size | 6,862,400 shares of ₹10 (aggregating up to ₹50.10 Cr) |
| Fresh Issue | 6,862,400 shares of ₹10 (aggregating up to ₹50.10 Cr) |
| Market Maker portion | 344,000 shares |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| P/E (x) | 13.22 |
| QIB Shares Offered | Not more than 50% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| Market Maker | GRETEX SHARE BROKING PVT. LTD. |
| Company Promoters | Mr. Hemal Vasantrai Mehta and Mr. Sachin Vasantrai Mehta are the Promoters of the company. |
Sudarshan Pharma Industries IPO Tentative Timetable
Sudarshan Pharma Industries IPO opens on Mar 9, 2023, and closes on Mar 14, 2023. The Sudarshan Pharma Industries IPO bid date is from Mar 9, 2023 10.00 A.M. to Mar 14, 2023 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 5 PM on the issue closing day.
| Event | Tentative Date |
|---|---|
| Opening Date | Mar 9, 2023 |
| Closing Date | Mar 14, 2023 |
| Basis of Allotment | Mar 17, 2023 |
| Initiation of Refunds | Mar 20, 2023 |
| Credit of Shares to Demat | Mar 21, 2023 |
| Listing Date | Mar 22, 2023 |
Sudarshan Pharma Industries IPO Lot Size
The Sudarshan Pharma Industries IPO lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹116,800).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹116,800 |
| Retail (Max) | 1 | 1600 | ₹116,800 |
| HNI (Min) | 2 | 3,200 | ₹233,600 |
Sudarshan Pharma Industries IPO Promoter Holding
| Pre Issue Share Holding | 80.28% |
| Post Issue Share Holding |
Sudarshan Pharma Industries IPO Prospectus
Company Contact Information
Sudarshan Pharma Industries Ltd
301,3rd Floor, Aura Biplex,
Above Kalyan Jewellers S. V. Road, Borivali (West)
Mumbai – 400092
Phone: 022- 42221111
Email: compliance@sudarshanpharma.com
Website: http://www.sudarshanpharma.com/
Sudarshan Pharma Industries IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: einward.ris@kfintech.com
Website: https://karisma.kfintech.com/